tissue microarray tissue cores (Azumaya Co Ltd)
90
Structured Review
Azumaya Co Ltd
tissue microarray tissue cores
Tissue Microarray Tissue Cores, supplied by Azumaya Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+microarray+cores/tissue+microarrayer/pmc12052773-98-6-24
Average 90 stars, based on 1 article reviews
Tissue Microarray Tissue Cores, supplied by Azumaya Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+microarray+cores/tissue+microarrayer/pmc12052773-98-6-24
Average 90 stars, based on 1 article reviews
tissue microarray tissue cores - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Blocking Assay:Article Title: An immunohistochemical scoring system of prolyl isomerase Pin1 for predicting relapse of prostate carcinoma after radical prostatectomy. Article Snippet: A major challenge for the management of prostate cancer (PCa) patients is to predict the clinical course of the disease after radical prostatectomy.. A previous comprehensive immunohistochemical analysis using an automated image analyzer suggested that prolyl isomerase Pin1 (hence Pin1) may be a potent predictor of recurrence in PCa patients.. However, a detailed pathological standard for evaluating the Pin1 immunohistochemistry in PCa has not been established yet. Microarray:Article Title: An immunohistochemical scoring system of prolyl isomerase Pin1 for predicting relapse of prostate carcinoma after radical prostatectomy. Article Snippet: A major challenge for the management of prostate cancer (PCa) patients is to predict the clinical course of the disease after radical prostatectomy.. A previous comprehensive immunohistochemical analysis using an automated image analyzer suggested that prolyl isomerase Pin1 (hence Pin1) may be a potent predictor of recurrence in PCa patients.. However, a detailed pathological standard for evaluating the Pin1 immunohistochemistry in PCa has not been established yet. |